Is there an association between complement activation and antiphospholipid antibody-related thrombosis?

Thrombosis and Haemostasis

Volumn 104, Issue 6, 2010, Pages 1279-1281

  Devreese, Katrien M J ^a   Hoylaerts, Marc F ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; LETTER; LUNG EMBOLISM; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; COMPLEMENT ACTIVATION; COMPLEMENT C3; HUMANS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS;

EID: 78649720936     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-06-0410     Document Type: Letter

References (22)

1. Meroni PL. Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 2008; 30: 99-103.
2. Giannakopoulos B, Passam F, Rahgozar S, et al. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109: 422-430.
3. Avalos I, Tsokos GC. The role of complement in the antiphospholipid syndrome-associated pathology. Clin Rev Allergy Immunol 2009; 36: 141-144.
4. Alijotas-Reig J, Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 2010; 65: 39-45.
5. Meroni PL, Gerosa M, Raschi E, et al. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol 2008; 34: 332-337.
6. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211-220. (Pubitemid 34461265)
7. Redecha P, Tilley R, Tencati M, et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007; 110: 2423-2431.
8. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10: 1222-1226.
9. Pierangeli SS, Vega-Ostertag M, Liu X, et al. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. Ann NY Acad Sci 2005; 1051: 413-420.
10. Fischetti F, Durigutto P, Pellis V, et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 2005; 106: 2340-236.
11. Munakata Y, Saito T, Matsuda K, et al. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis. Thromb Haemost 2000; 83: 728-731.
12. Romay-Penabad Z, Liu XX, Montiel-Manzano G, et al. C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies. Ann NY Acad Sci 2007; 1108: 554-566.
13. Boffa MC, Boinot C, De Carolis S, et al. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost 2009; 102: 25-28.
14. Stone S, Pijnenborg R, Vercruysse L, et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006; 27: 457-467.
15. Shamonki JM, Salmon JE, Hyjek E, et al. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007; 196: 167 e1-5.
16. Cavazzana I, Nebuloni M, Cetin I, et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 2007; 28: 160-164.
17. Oku K, Atsumi T, Bohgaki M, et al. Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 2009; 68: 1030-1035.
18. Leroyer AS, Anfosso F, Lacroix R, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010; 104: 456-463.
19. Distelmaier K, Adlbrecht C, Jakowitsch J, et al. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 2009; 102: 564-572.
20. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-1740.
21. Pierangeli SS, Girardi G, Vega-Ostertag M, et al. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005; 52: 2120-2124. (Pubitemid 40994335)
22. Peerschke EI, Yin W, Alpert DR, et al. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus 2009; 18: 530-538.